Page 99 - Prostate News Today

An evidence-based, expert consensus resource, available for free at NCCN.org/patientguidelines, helps people understand a rare and complex cancer type PLYMOUTH MEETING, Pa., Sept. 13, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network(NCCN) has published new NCCN Guidelines for Patients: Marginal Zone Lymphoma. A cancer of the lymphatic system, marginal zone lymphoma (MZL) is a type of non-Hodgkin B-cell lymphoma that is typically slow-growing, and comprises about 8% of non-Hodgkin l...

Company is introducing abiraterone film-coated tablets for treating metastatic prostate cancer - News - PharmaTimes

In a recent paper published in the American Journal of Clinical and Experimental Urology, researchers reviewed existing data on the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on the male genitourinary (GU) tract.

Muscat: In honour of the International Prostate Cancer Awareness Month, the Sultan Qaboos Comprehensive Cancer Centre’s (SQCCCRC) Genitourinary (GU) Cancers Program on Thursday...

HANNIBAL — As part of its observance of September as Prostate Cancer Awareness Month, Hannibal Clinic is hosting a free prostate cancer screening from 2-4 p.m. Wednesday, Sept. 21 in

So far this year more than 34,000 people have died from prostate cancer. But one local survivor is working to lower that number moving forward.

HANNIBAL — Hannibal Regional Medical Group is offering free prostate cancer screenings Sept. 20 as part of Prostate Cancer Awareness Month.

People in Los Angeles County experience differences in cancer risk and survival depending on a variety of factors such as race/ethnicity, gender, sexual orientation, geographic location and socioeconomic status, according to a new study by investigators at Cedars-Sinai Cancer.

Background: Biology-guided radiotherapy (BgRT) delivers dose to tumours triggered from positron emission tomography (PET) detection. Prostate specific membrane antigen (PSMA) PET uptake is abundant in the dominant intraprostatic lesion (DIL). This study investigates the feasibility of BgRT to PSMA-avid subvolume in the prostate region. Methods: Patients enrolled in the prospective randomized trial ProPSMA at our institution were included (ID: ANZCTR12617000005358). Gross tumour volumes (GTVs) we...

Millions of men face prostate issues, with treatment with drugs and surgery often making their problems worse. One ...